Skip to main content

Advertisement

Log in

Disparities in fertility preservation among patients diagnosed with female breast cancer

  • Fertility Preservation
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To investigate the association of specific patient factors with disparities in fertility preservation counseling and utilization of fertility preservation among patients ≤ 40 years old diagnosed with female breast cancer.

Methods

A retrospective chart review was conducted investigating patients diagnosed with breast cancer between January 2012 and December 2020 in a multi-site health system. Rates of fertility counseling and utilization of preservation services were compared based on age, race/ethnicity, parity, insurance type, and treatment site.

Results

Of the 6,783 patients diagnosed with female breast cancer, 306 (4.5%) were ≤ 40 years old at the time of diagnosis. There was no significant difference between Black or African American and White patients in rates of fertility counseling (12.1% vs 17.4%; p = 0.285) or pursuit of fertility preservation (3.3% vs 4.2%; p = 0.508), nor was a difference observed when compared by insurance type. However, younger patients (< 30 years of age), patients with 1 or no children, and patients treated in the more affluent county were more likely to undergo counseling and pursue fertility preservation than their matched counterparts.

Conclusion

Age, parity, and location of breast cancer care may impact rates of fertility counseling and preservation among reproductive age women diagnosed with breast cancer. Thus, further attention to age discrimination, a patient’s desire for future fertility, need for standardization in fertility preservation counseling, and perhaps implementation of comprehensive fertility coverage mandates across all states could help to improve gaps in fertility counseling and fertility preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Data are available with the permission of Henry Ford Health. The data that support the findings of this study are available from the corresponding author [MS] upon reasonable request.

References

  1. American Cancer Society. Breast Cancer Facts and Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf. Accessed 19 Mar 2023.

  2. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001. https://doi.org/10.1200/JCO.2018.78.1914.

    Article  PubMed  Google Scholar 

  3. Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. Cancer J. 2021;27:8–16. https://doi.org/10.1097/PPO.0000000000000500.

    Article  CAS  PubMed  Google Scholar 

  4. Goodman LR, Balthazar U, Kim J, Mersereau JE. Trends of socioeconomic disparities in referral patterns for fertility preservation consultation. Hum Reprod. 2012;27:2076–81. https://doi.org/10.1093/humrep/des133.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Walter JR, Xu S, Woodruff TK. A call for fertility preservation coverage for breast cancer patients: the cost of consistency. J Natl Cancer Inst. 2017;109:djx006. https://doi.org/10.1093/jnci/djx006.

    Article  Google Scholar 

  6. Meernik C, Engel SM, Wardell A, Baggett CD, Gupta P, Rodriguez-Ormaza N, Luke B, Baker VL, Wantman E, Rauh-Hain JA, Mersereau JE, Olshan AF, Smitherman AB, Cai J, Nichols HB. Disparities in fertility preservation use among adolescent and young adult women with cancer. J Cancer Surviv. 2022:. https://doi.org/10.1007/s11764-022-01187-y

  7. U.S. Census Bureau. "Population Estimates 2020–2022, Detroit, Michigan; United States." Quick Facts, https://www.census.gov/quickfacts/fact/table/detroitcitymichigan# Accessed 24 April 2023.

  8. Statista Research Department. “Median income of black private households in the United States from 1990 to 2021” Statista, 2022. https://www.statista.com/statistics/203295/median-income-of-black-households-in-the-us/. Accessed 2 October 2022.

  9. Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med. 2002;347:661–6. https://doi.org/10.1056/NEJMsa013491.

    Article  PubMed  Google Scholar 

  10. Henne MB, Bundorf MK. Insurance mandates and trends in infertility treatments. Fertil Steril. 2008;89:66–73. https://doi.org/10.1016/j.fertnstert.2007.01.167.

    Article  PubMed  Google Scholar 

  11. Peipert BJ, Montoya MN, Bedrick BS, Seifer DB, Jain T. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment. Reprod Biol Endocrinol. 2022;20:111. https://doi.org/10.1186/s12958-022-00984-5.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Villarreal-Garza C, Castro-Sánchez A, Platas A, Miaja M, Mohar-Betancourt A, Barragan-Carrillo R, et al. “Joven & Fuerte”: program for young women with breast cancer in Mexico -initial results. Rev Invest Clin. 2017;69:223–8. https://doi.org/10.24875/ric.17002280.

    Article  PubMed  Google Scholar 

  13. Lambertini M, Goldrat O, Barragan-Carrillo R, Vlglietti G, Demeestere I, Villarreal-Garza C. Viable options for fertility preservation in breast cancer patients: a focus on Latin America. Rev Invest Clin. 2017;69:103–13. https://doi.org/10.24875/ric.17002179.

    Article  CAS  PubMed  Google Scholar 

  14. U.S. Census Bureau. "Population Estimates 2017–2021, Detroit City, Michigan; Wayne County, Michigan; Macomb County, Michigan; Oakland County, Michigan; United States." https://www.census.gov/quickfacts//detroitcitymichigan,waynecountymichigan,macombcountymichigan,oaklandcountymichigan,US/RHI125221. Accessed 23 July 2023.

  15. Wald K, Wang A, Abel MK, Morris J, Letourneau JM, Mok-Lin E, Cedars MI, Rosen MP. Breast cancer grade and stage do not affect fertility preservation outcomes. J Assist Reprod Genet. 2022;39(5):1155–61. https://doi.org/10.1007/s10815-022-02473-5.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cioffi R, Mangili G, Sarais V, Cervini L, Longo V, Bergamini A, Stella Vanni V, Pagliardini L, Candiani M, Papaleo E. Do stage and grade of malignancy impact fertility preservation in breast cancer patients? J Gynecol Obstet Hum Reprod. 2021;50(10):102215. https://doi.org/10.1016/j.jogoh.2021.102215.

    Article  PubMed  Google Scholar 

  17. Marklund A, Lundberg FE, Eloranta S, Hedayati E, Pettersson K, Rodriguez-Wallberg KA. Reproductive outcomes after breast cancer in women with vs without fertility preservation. JAMA Oncol. 2021;7:86–91. https://doi.org/10.1001/jamaoncol.2020.5957.

    Article  PubMed  Google Scholar 

  18. Blondeaux E, Massarotti C, Fontana V, Poggio F, Arecco L, Fregatti P, Bighin C, Giannubilo I, Ruelle T, Razeti MG, Boni L, Anserini P, Del Mastro L, Lambertini M. The PREgnancy and FERtility (PREFER) Study Investigating the need for ovarian function and/or fertility preservation strategies in premenopausal women with early breast cancer. Front Oncol. 2021;3(11):690320. https://doi.org/10.3389/fonc.2021.690320.

    Article  CAS  Google Scholar 

  19. Sella T, Poorvu PD, Ruddy KJ, Gelber SI, Tamimi RM, Peppercorn JM, Schapira L, Borges VF, Come SE, Partridge AH, Rosenberg SM. Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 2021;127(16):2888–94. https://doi.org/10.1002/cncr.33596.

    Article  CAS  PubMed  Google Scholar 

  20. Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, et al. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 2012;118:4579–88. https://doi.org/10.1002/cncr.26649.

    Article  PubMed  Google Scholar 

  21. Howlader N, Cronin KA, Kurian AW, Andridge R. Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiol Biomarkers Prev. 2018;27(6):619–26. https://doi.org/10.1158/1055-9965.

    Article  CAS  PubMed  Google Scholar 

  22. Crown A, Muhsen S, Sevilimedu V, Kelvin J, Goldfarb SB, Gemignani ML. Fertility preservation in young women with breast cancer: impact on treatment and outcomes. Ann Surg Oncol. 2022;29(9):5786–96. https://doi.org/10.1245/s10434-022-11910-9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Voigt P, Persily J, Blakemore JK, Licciardi F, Thakker S, Najari B. Sociodemographic differences in utilization of fertility services among reproductive age women diagnosed with cancer in the USA. J Assist Reprod Genet. 2022;39:963–72. https://doi.org/10.1007/s10815-022-02455-7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lawson AK, McGuire JM, Noncent E, Olivieri JF Jr, Smith KN, Marsh EE. Disparities in counseling female cancer patients for fertility preservation. J Womens Health (Larchmt). 2017;26:886–91. https://doi.org/10.1089/jwh.2016.5997.

    Article  PubMed  Google Scholar 

  25. Peipert BJ, Chung EH, Harris BS, Jain T. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States. Am J Obstet Gynecol. 2022;227(64):e1-8. https://doi.org/10.1016/j.ajog.2022.03.003.

    Article  Google Scholar 

  26. Voigt PE, Blakemore JK, McCulloh D, Fino ME. Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in New York City. J Assist Reprod Genet. 2020;37(12):3095–102. https://doi.org/10.1007/s10815-020-01980-7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yeung SY, Ng EYL, Lao TTH, Li TC, Chung JPW. Fertility preservation in Hong Kong Chinese society: awareness, knowledge and acceptance. BMC Womens Health. 2020;20(1):86. https://doi.org/10.1186/s12905-020-00953-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monique Swain.

Ethics declarations

Ethics approval

This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of the Henry Ford Health System who granted a waiver of ethical approval for the project.

Consent to participate

This research study was conducted retrospectively from de-identified data obtained for clinical purposes, therefore consent to participate was not required.

Competing interest

The authors report no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Swain, M., Miller, M., Cannella, C. et al. Disparities in fertility preservation among patients diagnosed with female breast cancer. J Assist Reprod Genet 40, 2843–2849 (2023). https://doi.org/10.1007/s10815-023-02968-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-023-02968-9

Keywords

Navigation